Background: Food allergies pose a considerable world-wide public health burden with
detected in the replication sample (P=.03, OR=1.37, CI=1.03-1.82) and further supported by a meta-analysis (P=.0006, OR=1.50). However, we cannot rule out an association with food sensitization. Carriage of the rs1295686 variant A allele was also associated with elevated total plasma IgE.
Conclusions and Clinical Relavance:
We show for the first time, in two independent cohorts, that IL13 polymorphism rs1295686 (in complete linkage disequilibrium with functional variant rs20541) is associated with challenge-proven food allergy.
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| INTRODUCTION
Interleukin-13 has a well-described role in mediating Immunoglobulin E (IgE) class switching and is necessary for the development of T-helper type 2 (Th2)-mediated allergic immune responses.
1 IL-13-deficient mice exhibit impaired Th2 development and reduced Th2 cytokine production and IgE levels. 1 In humans, polymorphisms at IL13 have been studied in the context of asthma, eczema and atopy. [2] [3] [4] [5] [6] [7] [8] [9] [10] IL13 is one of the most replicated asthma and atopy genetic associations. Variants at IL13 have been linked to elevated cord blood IgE (cbIgE) 11, 12 and elevated IgE at 12 months, 2, 4 and 8 years of age. 13, 14 Of the 21 SNPs associated with cbIgE in the Yang et al. study, an IL13 polymorphism was one of the two SNPs with highest predictive accuracy for cbIgE. 12 One well-studied variant, rs20541 (IL13+2044GA), produces an IL-13 gain of function amino acid substitution (Arg130Gln) variant with notably higher induction of downstream processes including CD23 monocyte expression and IgE class switching in B cells. 15, 16 Another variant rs1800925 enhances IL-13 production in Th2 polarized cells and has been associated with asthma, eczema and sensitization to foods. 
| Genotyping and quality control
Genomic DNA derived from peripheral blood samples (n=836) were genotyped using Agena Bioscience iPLEX Gold chemistry and the MassARRAY mass spectrometer system according to manufacturer's instructions. Quality control of genotyping data was conducted in PLINK. 22 Samples with a genotyping success rate of less than 95%
were excluded (n=59), resulting in a final post-QC sample size of 722 in the HealthNuts discovery cohort of 12-month-old infants;
367 food allergy cases, 199 food sensitized but tolerant cases and 156 non-food allergic controls (Table S1 ). All nine IL13 tag SNPs passed QC with a genotype call rate of ≥95%, and there was no evidence of significant deviation from the Hardy-Weinberg Equilibrium (HWE) (P<.01).
| Discovery phase statistical analysis
We compared allele frequencies between cases and controls using the Cochran-Mantel-Haenszel (CMH) test in the PLINK software, 22 which controls for heterogeneity arising from population stratification using an "average" odds ratio. The total plasma IgE data were positively skewed and thus log-transformed prior to analysis. The linear regression test in PLINK was used to test for an association between IL13 variants and log-transformed total plasma IgE, adjusted for food allergy as a covariate.
| Replication phase
Candidate gene associations were replicated in an independent paediatric sample from multiple Melbourne-based studies with compara- 25 and 38 food allergic cases from the Probiotic and Peanut Oral Immuno-Therapy study (PPOIT). 26 Demographics and clinical characteristics are presented in (Table S2) . The replication cohort genotyping data were analysed in PLINK using logistic regression models adjusted for population stratification using the first and second principal components (PCs). Meta-analysis of discovery and replication samples was conducted in PLINK with random-and fixed-effects models to assess any heterogeneity of effect sizes between studies (570 food allergic cases and 486 nonfood allergic controls).
| RESULTS
Following genotyping and quality control, 367 of 722 (50.8%) participating infants with blood samples in the discovery phase of the study had clinical food allergy. Egg allergy was the most common type of food allergy (89.3%), followed by peanut allergy (36.2%) while allergy to sesame was less common (6.7%). Food sensitized or food allergic infants were more likely to be male with one or more Asian parents. Eczema rates were higher in the food allergy group (56.4%) (Table S1 ). Table S3 ). We also adjusted for atopic morbidities using logistic regression, which did not materially alter the pattern of association (Table S4 ). 
| SNPs in IL13 are associated with variations in total plasma IgE
Total plasma IgE measures were available for 423 individuals from the discovery study (69 non-food allergic, 106 food sensitized but tolerant and 248 food allergic). We tested log IgE titres as the dependent variable in a regression analysis using genotyped allele frequencies as predictors. The strongest evidence for an association with IgE titres was with the minor allele of rs1295686, which was associated with elevated log-transformed total plasma IgE levels (P=.0003, SE=0.10, Beta=0.38). There was also evidence that three additional variants (rs3091307, rs1800925 and rs1295683) were associated with elevated IgE levels (Table S5 and Fig. S2 ).
| Replication confirms IL13 variant rs1295686 is associated with food allergy
To support our findings from the discovery phase, we genotyped rs1295686 and rs1295687 in an additional 533 independently selected children. In the replication sample, egg allergy was again the most common food allergy (72.5%), followed by peanut (62.1%).
Eczema was more common among food allergic children (41.9%), and there was a higher proportion of Europeans (78.5%) in the control group.
In a logistic regression analysis adjusted for ancestry, we replicated the association between food allergy and rs1295686 in the independent sample group (P=.03, OR=1.37, CI=1.03-1.82) (Table 2A) . A sensitivity analysis of infants without eczema (96 food allergic cases and 201 non-food allergic controls) again did not suggest eczema was a significant confounder. The rs12954687 SNP did not show evidence of an association with phenotype in this population (Table 2A ). To maximize the study power, we performed a meta-analysis of both discovery and replication samples. Genotyped SNP rs1295686 remained the top associated variant (P=.0006, OR=1.50, Q=0.31, I=3.32), while rs1295687 was not associated (Table 2B) . In this analysis, the P-value for Cochrane's Q statistic (Q) and I 2 heterogeneity index (I) (0-100) was indicative of low heterogeneity of effect sizes between study populations.
| DISCUSSION
Genetic variants at IL13 have been reported to increase the risk of a range of atopic conditions including asthma 3,6,7,9 and eczema. *P is the P-value determined by CMH testing with clusters defined by parental country of birth, A1 is the effect allele, OR is the odds ratio, and L95 and U95 are the lower and upper 95% confidence intervals. (eczema rates, ethnicity strata, age of diagnosis), and criteria used for phenotyping (OFC, 95%PPV), a meta-analysis across both cohorts suggested limited heterogeneity of observed effect sizes between studies, indicative of a robust association. We also found evidence that rs1295686 was associated with elevated total plasma IgE levels supporting a functional role in disease aetiology.
The rs1295686 variant is a T -> C polymorphism located in the intronic region of IL13 that has previously been associated with asthma in a consortium-based meta-analysis, 6 with dysregulated total plasma IgE in a US population, 4 and with elevated cord blood plasma IgE levels. 11, 14 This particular functional variant is in complete linkage disequilibrium with rs20541 ( Fig. S1 ), an A -> G missense mutation that has previously been linked to allergic rhinitis in a meta-analysis of eight studies, 10 asthma in a meta-analysis of 34 studies 7 and elevated IgE levels. 4 In our study, we found evidence that rs1295686 was associated with elevated plasma IgE levels in addition to food sensitization and food allergy; however, we are unable to distinguish which variant is driving these associations, and future fine-mapping studies would be needed to resolve this.
A strength of this study was the robust phenotyping measures in the discovery cohort determined by open food challenge with predetermined, objective diagnostic criteria, standard for infants as per PRACTALL food challenge guidelines. 29 These measures provide the study with the rare opportunity to distinguish between the mechanisms of allergic sensitization and clinical food allergy. We found only weak evidence (P=.06) that rs1295686 was associated with food sensitization although the direction and size of the effect was consistent with that observed for the association between rs1295686 and clinical food allergy. These observations suggest that the lack of association was most likely a function of reduced sample size. There was no evidence of an effect when clinically allergic cases were compared to sensitized tolerant controls suggesting that variant rs1295686 increases the risk of food allergy via sensitization to dietary antigen.
We carefully addressed the issue of population structure in the discovery phase by CMH analyses with clusters defined by parental country of birth and validated our categories using genomewide SNP data. In the replication sample, population structure was adjusted for with principal components. One limitation of the study was the absence of challenge-proven food allergy phenotyping measures in some of the studies utilized for replication, instead relying upon 95% PPV definitions. This may have led to inclusion of some food sensitized but tolerant individuals in the groups and/or the exclusion of some true food allergy cases. We addressed this by comparing effect sizes across the different study populations within the replication sample, which did not suggest phenotype definition or age at diagnosis between studies as a significant source of heterogeneity.
Our study establishes association between food allergy and IL13 genetic variation in two Australian food allergy samples. Further independent studies to confirm and extend these findings are now warranted. Understanding the genetic factors and molecular pathways that contribute to perturbation of Th2 immune responses will assist in the development of novel therapeutic approaches to immune-mediated diseases.
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